Pheton Holdings Income from Continuous Operations 2025-2024 | PTHL
Pheton Holdings income from continuous operations from 2025 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Pheton Holdings Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-1 |
| 2023 | $0 |
| 2022 | $0 |
| Pheton Holdings Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.027B | $0.000B |
| Pheton Holdings Ltd, through its wholly owned operating subsidiary, Beijing Feitian Zhaoye Technology Co., Ltd., focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its lead product includes Beijing Feitian's Treatment Planning System. Pheton Holdings Ltd is based in BEIJING, China. | |||